Sally Dunwoodie | |
---|---|
Personal details | |
Born | Sally Lewers Dunwoodie |
Nationality | Australian |
Occupation | Embryologist, geneticist |
Sally Lewers Dunwoodie is an Australian scientist, specialising in genetic birth defects. [1]
Dunwoodie became an Officer of the Order of Australia in 2024 "For distinguished service to medical research as an embryologist and geneticist, particularly in the field of fetal and neonatal heart disease". [2]
Dunwoodie attended Queenwood School for Girls in Sydney, Australia, graduating in 1981. [3] She studied a Bachelor of Science with Honours at the University of Sydney. [4] She graduated with a PhD from the Children's Medical Research Institute. [4]
Dunwoodie completed postdoctoral training at the National Institute for Medical Research before starting work at the Victor Chang Cardiac Research Institute in 2000. [5] In 2022, Dunwoodie became the Deputy Director of the Victor Chang Cardiac Research Institute. [4]
Dunwoodie has two children. [2]
Victor Peter Chang was a Chinese-born Australian cardiac surgeon and a pioneer of modern heart transplantation in Australia.
Mario Ramberg Capecchi is an Italian-born molecular geneticist and a co-awardee of the 2007 Nobel Prize in Physiology or Medicine for discovering a method to create mice in which a specific gene is turned off, known as knockout mice. He shared the prize with Martin Evans and Oliver Smithies. He is currently Distinguished Professor of Human Genetics and Biology at the University of Utah School of Medicine.
Sir Martin John EvansFLSW is an English biologist who, with Matthew Kaufman, was the first to culture mice embryonic stem cells and cultivate them in a laboratory in 1981. He is also known, along with Mario Capecchi and Oliver Smithies, for his work in the development of the knockout mouse and the related technology of gene targeting, a method of using embryonic stem cells to create specific gene modifications in mice. In 2007, the three shared the Nobel Prize in Physiology or Medicine in recognition of their discovery and contribution to the efforts to develop new treatments for illnesses in humans.
Robinow syndrome is an extremely rare genetic disorder characterized by short-limbed dwarfism, abnormalities in the head, face, and external genitalia, as well as vertebral segmentation. The disorder was first described in 1969 by human geneticist Meinhard Robinow, along with physicians Frederic N. Silverman and Hugo D. Smith, in the American Journal of Diseases of Children. By 2002, over 100 cases had been documented and introduced into medical literature.
St Vincent's Hospital, Sydney is a leading tertiary referral hospital and research facility located in Darlinghurst, Sydney. Though funded and integrated into the New South Wales state public health system, it is operated by St Vincent's Health Australia. It is affiliated with the University of Tasmania College of Health and Medicine and the University of New South Wales Medical School.
The Victor Chang Cardiac Research Institute (VCCRI) is an Australian non-profit medical research facility that is dedicated to finding cures for cardiovascular disease. With headquarters located in Darlinghurst, New South Wales, the research hub is home to more than 20 research laboratories and the Victor Chang Cardiac Research Institute Innovation Centre. The institute's mission is "the relief of pain and suffering, and the promotion of well-being, through an understanding of the fundamental mechanisms of cardiovascular disease". Its key research is focused on the prevention and treatment of various heart diseases, including arrhythmia, cardiac arrest, cardiomyopathy, congenital heart disease, heart attack, heart failure, high cholesterol, obesity, spontaneous coronary artery dissection (SCAD) and stroke.
Spondylocostal dysostosis, also known as Jarcho-Levin syndrome (JLS), is a rare, heritable axial skeleton growth disorder. It is characterized by widespread and sometimes severe malformations of the vertebral column and ribs, shortened thorax, and moderate to severe scoliosis and kyphosis. Individuals with Jarcho-Levin typically appear to have a short trunk and neck, with arms appearing relatively long in comparison, and a slightly protuberant abdomen. Severely affected individuals may have life-threatening pulmonary complications due to deformities of the thorax. The syndrome was first described by Saul Jarcho and Paul M. Levin at Johns Hopkins University in 1938.
Heart- and neural crest derivatives-expressed protein 1 is a protein that in humans is encoded by the HAND1 gene.
Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe, also known as Lunatic Fringe, is a protein encoded in humans by the LFNG gene.
Delta-like 3 (Drosophila), also known as DLL3, is a protein which in humans is encoded by the DLL3 gene. Two transcript variants encoding distinct isoforms have been identified for this gene.
Zeng Fanyi is a Chinese stem cell scientist and professor at Shanghai Jiao Tong University (SJTU) medical school.
TBX20 (gene) is a member of the T-box family that encodes the transcription factor TBX20. Studies in mouse, human and fruitfly have shown that this gene is essential for early heart development, adult heart function and yolk sac vasculature remodeling and has been associated with congenital heart diseases. Tbx20 was also shown to be required for migration of hindbrain motor neurons and in facial neurons was proposed to be a positive regulator of the non-canonical Wnt signaling pathway.
Paul Ivan Korner AO was a Czech–Australian cardiac physiologist noted for his contributions to the understanding of hypertension, especially essential hypertension.
T-box 6 is a protein that in humans is encoded by the TBX6 gene.
Steven Mark Lowy is a leading Australian businessman and philanthropist. He is the former co-chief executive officer of Westfield Corporation, a leading global shopping centre company that was acquired by French company Unibail-Rodamco in 2018 in what was one of the largest transactions in Australian corporate history. His principal activities now focus on investments associated with the Lowy family’s private company, Lowy Family Group, as well as a number of philanthropic and community roles including as Deputy Chairman of Australia's leading foreign policy think tank, the Lowy Institute; a director of the Lowy Foundation and Lowy Medical Research Foundation; Chairman of the World Board of Trustees of Keren-Hayesod United Israel Appeal and President of the Hakoah Club.
(HES7) or bHLHb37 is protein coding mammalian gene found on chromosome 17 in humans. HES7 is a member of the Hairy and Enhancer of Split families of Basic helix-loop-helix proteins. The gene product is a transcription factor and is expressed cyclically in the presomitic mesoderm as part of the Notch signalling pathway. HES7 is involved in the segmentation of somites from the presomitic mesoderm in vertebrates. The HES7 gene is self-regulated by a negative feedback loop in which the gene product can bind to its own promoter. This causes the gene to be expressed in an oscillatory manner. The HES7 protein also represses expression of Lunatic Fringe (LFNG) thereby both directly and indirectly regulating the Notch signalling pathway. Mutations in HES7 can result in deformities of the spine, ribs and heart. Spondylocostal dysostosis is a common disease caused by mutations in the HES7 gene. The inheritance pattern of Spondylocostal dysostosis is autosomal recessive.
Richard Paul Harvey is a molecular biologist, the Sir Peter Finley professor of Heart Research at the University of New South Wales and Deputy Director and Head of the Developmental and Stem Cell Biology Division at the Victor Chang Cardiac Research Institute.
Robert Williamson is a retired British-Australian molecular biologist who specialised in the mapping, gene identification, and diagnosis of human genetic disorders.
Kenro Kusumi is a genome biologist and professor, dean of The College of Liberal Arts and Sciences and senior vice provost at Arizona State University.
Robert Michael Graham is an Australian-born clinician-scientist. He is the Des Renford Professor of Medicine at University of New South Wales and the Head of the Molecular Cardiology and Biophysics Division at Victor Chang Cardiac Research Institute.